The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125414123 12541412 3 F 20160704 20160708 20160718 EXP US-JNJFOC-20160700725 JOHNSON AND JOHNSON WILLIAMS K, DELEON S. COUGH AND LIP SLOUGH: THE SEARCH FOR A UNIFYING DIAGNOSIS. PEDIATRICS IN REVIEW JUN-2016;37 (6):P.E22-E24. 7.00 YR C M Y 0.00000 20160718 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125414123 12541412 1 PS CETIRIZINE HYDROCHLORIDE. CETIRIZINE HYDROCHLORIDE 1 Unknown U U 19835 UNKNOWN
125414123 12541412 2 SS CETIRIZINE HYDROCHLORIDE. CETIRIZINE HYDROCHLORIDE 1 Unknown U U 19835 UNKNOWN
125414123 12541412 3 SS DIPHENHYDRAMINE HYDROCHLORIDE. DIPHENHYDRAMINE HYDROCHLORIDE 1 Unknown U U 999999 UNSPECIFIED
125414123 12541412 4 SS ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) AS NEEDED U 0 UNSPECIFIED
125414123 12541412 5 SS ALUMINIUM HYDROXIDE W/MAGNESIUM HYDROXIDE ALUMINUM HYDROXIDEMAGNESIUM HYDROXIDE 1 Unknown AS NEEDED U 0 UNSPECIFIED
125414123 12541412 6 SS LIDOCAINE. LIDOCAINE 1 Unknown U 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125414123 12541412 2 Respiratory symptom
125414123 12541412 3 Oral pain
125414123 12541412 4 Respiratory symptom
125414123 12541412 5 Oral pain
125414123 12541412 6 Oral pain

Outcome of event

Event ID CASEID OUTC COD
125414123 12541412 HO
125414123 12541412 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125414123 12541412 Conjunctivitis
125414123 12541412 Drooling
125414123 12541412 Drug ineffective for unapproved indication
125414123 12541412 Face oedema
125414123 12541412 Hypoaesthesia oral
125414123 12541412 Hypoxia
125414123 12541412 Lip exfoliation
125414123 12541412 Lip swelling
125414123 12541412 Mucosal inflammation
125414123 12541412 Mycoplasma infection
125414123 12541412 Off label use
125414123 12541412 Oral pain
125414123 12541412 Pneumonia mycoplasmal
125414123 12541412 Post-tussive vomiting
125414123 12541412 Rash maculo-papular
125414123 12541412 Tongue ulceration
125414123 12541412 Urethritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found